Reduced Clearance of Phenobarbital in Advanced Cancer Patients near the End of Life

European Journal of Drug Metabolism and Pharmacokinetics
Hirokazu NakayamaToshiaki Kato

Abstract

Little is known about the pharmacokinetics of phenobarbital in terminally ill cancer patients. We investigated whether phenobarbital clearance alters depending on the length of survival. We retrospectively reviewed the clinical, laboratory, and therapeutic drug monitoring (TDM) records of patients who received parenteral or oral phenobarbital for 21 consecutive days or longer between 2000 and 2016. Patients were divided into non-cancer and cancer groups. Cancer patients were further stratified according to the survival interval after TDM: those who survived > 3 months were classified as long-surviving and the remainders short-surviving cancer patients. Phenobarbital clearance (CLPB) was calculated at steady state. Multiple comparisons of median CLPB were conducted among the three groups. Data were collected from 44 non-cancer patients and 34 cancer patients comprising 24 long-surviving and 10 short-surviving cancer patients. Among 10 short-surviving cancer patients, 4 had hepatic metastasis. Median CLPB (range) in short-surviving cancer patients [0.076 (0.057‒0.114) L/kg/day] was significantly (p < 0.05) lower than that in non-cancer patients [0.105 (0.060‒0.226) L/kg/day] and in long-surviving cancer patients [0.100 (0.082‒0.1...Continue Reading

References

Feb 1, 1982·Journal of Clinical Pharmacology·E NelsonD Perrier
Apr 1, 1980·Journal of Neurology, Neurosurgery, and Psychiatry·M FeelyN Callaghan
Jan 1, 1994·European Journal of Clinical Pharmacology·I BernusM J Eadie
Jan 1, 1996·Journal of Gastroenterology and Hepatology·J GeorgeG C Farrell
Jun 4, 1999·Journal of Pain and Symptom Management·L C StirlingA Tookman
Nov 1, 2005·Journal of Pain and Symptom Management·Tatsuya MoritaUNKNOWN Japan Pain, Palliative Medicine, Rehabilitation, and Psycho-Oncology Study Group
Jan 26, 2008·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Edward T MorganChristopher J Sinal
Feb 8, 2011·The Lancet Oncology·Kenneth FearonVickie E Baracos
Apr 19, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Marina KacevskaGraham R Robertson
Sep 1, 2012·The Lancet Oncology·Michael WellerWolfgang Wick
Nov 9, 2014·European Journal of Clinical Pharmacology·Katarina VučićevićMilica Prostran
Apr 8, 2015·Journal of Pain and Symptom Management·Koji AmanoTatsuya Morita
Aug 28, 2016·European Journal of Clinical Pharmacology·Hikaru SatoJunichi Kawakami
Feb 9, 2017·British Journal of Clinical Pharmacology·Linda G FrankenRon A A Mathot

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
sedation

Software Mentioned

SPSS Statistics

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Journal of the Association of Physicians of India
R S Chandra, N A Kshirsagar
Nihon rinsho. Japanese journal of clinical medicine
Y GomitaY Araki
BMJ : British Medical Journal
J JobbinsR G Newcombe
© 2022 Meta ULC. All rights reserved